Drug class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
11 drugs the FDA files under Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, and that we can price. Drugs in one class are not interchangeable — they share a mechanism, not a dose or a set of side effects — but the price gap between them is often large, and it is a reasonable thing to raise with a prescriber.
- DoravirineHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Doravirine, lamivudine and tenofovirHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
- Efavirenz · 3 strengths and formsHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor$326.47Cost Plus Drugs
- Efavirenz, emtricitabine and tenofovirHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor$21.40Cost Plus Drugs
- Efavirenz, lamivudine and tenofovirHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor$955.97Cost Plus Drugs
- Etravirine · 2 strengths and formsHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor$99.57Cost Plus Drugs
- Nevirapine · 2 strengths and formsHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor$13.73Cost Plus Drugs
Cheapest option we hold for the usual fill, fees included, checked November 5, 2026. Open a medicine for every option and the date on each one.